Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchWithdrawnNCT05015972
What this trial is testing

UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies

Who this might be right for
B-cell Lymphoma
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Not applicableStudy completedNCT06362772
What this trial is testing

Clinical Efficacy of 125I Seed Implantation in the Treatment of Refractory Differentiated Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Jiangxi Provincial Cancer Hospital 36
Early research (Phase 1)Looking for participantsNCT07369895
What this trial is testing

Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
O&D BioTech Group CO., Limited 18
Early research (Phase 1)Ended earlyNCT05274451
What this trial is testing

Investigate LYL797 in Adults With Solid Tumors

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more
Lyell Immunopharma, Inc. 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT01589302
What this trial is testing

PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia

Who this might be right for
Prolymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory/Relapsed Chronic Lymphocytic Leukemia
Kami Maddocks, MD 154
Large-scale testing (Phase 3)Looking for participantsNCT06943872
What this trial is testing

Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
BeOne Medicines 630
Testing effectiveness (Phase 2)Active Not RecruitingNCT03672773
What this trial is testing

Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Recurrent Extensive Stage Small Cell Lung CarcinomaRefractory Extensive Stage Small Cell Lung Carcinoma
Jonsson Comprehensive Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00055653
What this trial is testing

Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT02008383
What this trial is testing

Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
John Strickler, M.D. 29
Post-approval studies (Phase 4)Study completedNCT00574470
What this trial is testing

Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD

Who this might be right for
Graft vs Host Disease
University of Iowa 3
Early research (Phase 1)Study completedNCT00081237
What this trial is testing

OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 15
Testing effectiveness (Phase 2)Looking for participantsNCT06611007
What this trial is testing

Evaluation of the Safety of LipiodolⓇ Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment

Who this might be right for
Osteoarthritis
University Hospital, Grenoble 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439344
What this trial is testing

Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT03314181
What this trial is testing

Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
AbbVie 156
Not applicableLooking for participantsNCT06450067
What this trial is testing

Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Juventas Cell Therapy Ltd. 200
Testing effectiveness (Phase 2)Study completedNCT03343665
What this trial is testing

Treatment With Nivolumab at the Fixed Dose 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkins Lymphoma

Who this might be right for
Hodgkin Lymphoma
St. Petersburg State Pavlov Medical University 30
Not applicableLooking for participantsNCT06355739
What this trial is testing

CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+

Who this might be right for
B Lymphocytic LeukemiaB Lymphoblastic Lymphoma
Zhu Xiaofan 60
Not applicableStudy completedNCT03204981
What this trial is testing

Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias

Who this might be right for
Ventricular Arrythmia
Vivek Reddy 52
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Not applicableUnknownNCT04771065
What this trial is testing

Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Intractable Epilepsy

Who this might be right for
Refractory Epilepsy
University Hospital, Montpellier 10
Next Page